By SABRINA TAVERNISE
The group is expected to recommend approval of a cheaper copy of a special cancer drug, which could lead to generic copies of expensive medications.
Published: January 8, 2015 at 01:00AM
from NYT Science Read the full article here: https://ift.tt/1wV8khh
via IFTTT